Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology*; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D009206:Myocardium / Q000201:enzymology; D010424:Pentobarbital / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism; D011412:Propanolamines / Q000494:pharmacology*; D051381:Rats
D000319:Adrenergic beta-Antagonists; D005029:Ethylenediamines; D010647:Phenyl Ethers; D011412:Propanolamines; D006005:Phosphorylases; D010424:Pentobarbital; D007545:Isoproterenol; D004837:Epinephrine